December 8, 2021
Lumira Co-Leads OncoMyx $50 Million Series B to Advance a Novel Immuno-Oncology Platform that Delivers Multiple Cancer-Killing Payloads
October 26, 2021
Lumira Ventures Announces First Investment from the Angellini Lumira Biosciences Fund in GenEp
July 26, 2021
Lumira Ventures Closes on US$255 Million of New Capital to Build Transformative Healthcare Companies
No current content.